Literature DB >> 6387263

Long-term effect of captopril on kidney function in various forms of hypertension.

W Vetter, M Wehling, E C Foerster, U Kuhlmann, H J Boerlin, P Greminger, H Vetter.   

Abstract

To study long-term effects of captopril on renal function in patients with various forms of severe hypertension, serum creatinine values were monitored in 76 patients under captopril therapy over a period of up to 3 years. Three different groups were formed: patients with essential hypertension (n = 37); patients with renovascular hypertension (n = 20); patients with renal parenchymatous hypertension (n = 19). In each of the three groups reduction in blood pressure was accompanied by increases in serum creatinine. However, both changes were more pronounced in patients with renovascular hypertension. In this group only the rise in creatinine was statistically significant and showed a slight progression with duration of captopril treatment. Group specific analysis revealed that the increase was smaller in patients with unilateral (n = 16) renovascular disease than in those with bilateral (n = 4) involvement, but in the former it was still significantly higher than in patients with essential or renal parenchymatous hypertension. Separation of patients according to the underlying disease of renovascular hypertension showed that renal function deteriorated less in patients with arteriosclerotic origin (n = 10) than in those with fibromuscular dysplasia (n = 8). Statistical evaluation of subjects with renovascular and essential hypertension still revealed significant differences in creatinine when the patients with initial plasma renin activity (PRA) below and above 6 ng/ml X 3 h were compared separately. A significant correlation (r = 0.73; P less than 0.05) between blood pressure reduction and creatinine changes was obtained only for patients with renovascular hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387263     DOI: 10.1007/bf01725707

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  24 in total

1.  Reversible renal failure during treatment with captopril.

Authors:  P R Farrow; R Wilkinson
Journal:  Br Med J       Date:  1979-06-23

2.  Reversible renal failure during treatment with captopril.

Authors:  P Collste; K Haglund; G Lundgren; G Magnusson; J Ostman
Journal:  Br Med J       Date:  1979-09-08

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  Captopril: reversible renal failure with severe hyperkalaemia.

Authors:  A Grossman; D Eckland; P Price; C R Edwards
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

5.  Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.

Authors:  J J Curtis; R G Luke; J D Whelchel; A G Diethelm; P Jones; H P Dustan
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

6.  Nephrotic syndrome from captopril.

Authors:  Y K Seedat
Journal:  S Afr Med J       Date:  1980-03-15

7.  Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.

Authors:  N K Hollenberg; S L Swartz; D R Passan; G H Williams
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

8.  Long-term efficacy of captopril in renovascular and essential hypertension.

Authors:  D B Case; S A Atlas; R M Marion; J H Laragh
Journal:  Am J Cardiol       Date:  1982-04-21       Impact factor: 2.778

9.  Proteinuria during long-term captopril therapy.

Authors:  D B Case; S A Atlas; J A Mouradian; R A Fishman; R L Sherman; J H Laragh
Journal:  JAMA       Date:  1980-07-25       Impact factor: 56.272

10.  Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension.

Authors:  T J Moore; F R Crantz; N K Hollenberg; R J Koletsky; M S Leboff; S L Swartz; L Levine; S Podolsky; R G Dluhy; G H Williams
Journal:  Hypertension       Date:  1981 Mar-Apr       Impact factor: 10.190

View more
  5 in total

Review 1.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

Review 2.  Angiotensin-converting enzyme inhibitors in chronic renal failure.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics.

Authors:  G S Thind
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

4.  Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

5.  [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].

Authors:  K O Stumpe
Journal:  Klin Wochenschr       Date:  1985-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.